Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 April 2024 | Story Leonie Bolleurs | Photo Supplied
Eco-vehicles race
Join the UFS on 18 May 2024 from 10:00-13:00 at the Red Square Parking area for the seventh annual Kovsie ACT Eco-Vehicle Race. Come and support your favourite team to victory!

Kovsie ACT at the University of the Free State (UFS) proudly presents the seventh Kovsie Eco-Vehicle Race, set to take place at the Equitas Parking area on the Bloemfontein Campus.

According to Karen Scheepers, Assistant Director: Student Life, ten teams will be participating in this year’s race, featuring the three UFS campuses as well as the Central University of Technology. The event promise excitement like never before.

Scheepers says, besides an exciting race, spectators can look forward to a new track and viewing area. She invites the public, staff and students to come and support the competing teams as they showcase their skills on the racetrack.

Event details:

  • Date: Saturday 18 May 2024
  • Time: 10:00-13:00
  • Venue: Red Square Parking area (opposite George du Toit Building)

Breakdown of the programme:

09:00 -10:15 Performance by student artists 
10:15 -10:35 Walkthrough by judges
10:35 -10:40 Welcoming
10:40 Races commence
12:30 -13:00 Announcement of winners

13:00 -14:00 Performance by student artists

The Eco-Vehicle Race marks the culmination of a nine-month co-curricular skills programme, aimed at empowering participating students with a set of skills for the world of work. Through this programme, they are equipped with basic knowledge and abilities on sustainable energy, enabling them not only to compete in the eco-vehicle race but also to comprehend the inner workings of the vehicle. This understanding is important to the teams for when they are doing repairs during the race.

Students will be competing in three events:

• Obstacle course: Teams will be challenged by obstacles to test their control over the car.
• Smart lap: A timed lap in which the drivers take the main track for the first time.

• Endurance race: The teams need to finish as many laps as possible using the least amount of energy in 45 minutes.

The winners of the three events will each be awarded a trophy. Additionally, there will be a trophy for the best pit stop as well as a spirit cup for the team with the best energy and support from the audience.

For more information, contact Teddy Sibiya.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept